SteadySharesSteadySharesSteadySteShares
The market
MarketsDiscover
Follow the money
Smart MoneyPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Open
SteadySharesMarketsDiscoverSmart MoneyMy WealthPoliticiansCryptoNews
/
DiscoverPRCT
TechnologyNasdaqGMUSD

PROCEPT BioRobotics Corporation

$0012345678900123456789.0012345678900123456789-3.1%
52w low (est.) $14.69$23.62 52w high (est.)
Market data
52w range
USD17.96 - USD62.17
Beta
1.00
Sector
Technology

About PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Valuation

Overall Rating
0
Not rated
Not rated
Moat Score0
DCF Intrinsic Value
Not covered by our valuation model yet.

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD0.00
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
0.0%
Profit Margin
0.0%
ROE
0.0%
Debt / Equity
0.00
Beta
1.00
vs Technology sector:Moat 0 vs 10Yield 0.00% vs 0.1%

Statistics

Similar Stocks · Technology

MSFT78
$441.20+0.8%
AAPL74
$228.50+1.2%
AVGO74
$1,700.00+1.4%
NVDA71
$124.30+3.4%

Latest News · PRCT